Skip to main content
editorial
. 2018 Jan 2;151(1):4–5. doi: 10.1177/1715163517745517

Table 1.

Literature review

Study author Date Setting/country Disease Frequency of pharmacist contact with patient per year (median, IQR) Comparison group (median, IQR)
McNamara et al.1 2012 Wimmera/Australia
N = 694 patients
CVD (or risk factors for) Overall: (2, 0-10) Overall: (GPs) (3, 1-6)
Age <65 years Age 25-44 years
(1, 0-3) n = 94Age 45-54 years
(2, 0-6) n = 161Age 55-64 years
(2, 0-10) n = 162
Age <65 years
(GPs)
Age 25-44 years
(2, 1-4) n = 94Age 45-54 years
(2, 1-5) n = 161Age 55-64 years
(3, 1-5) n = 162
Age >65 years Age 65-74 years
(6, 0-10) n = 161Age 75-84 years
(10, 1-12) n = 116
Age >65 years
(GPs)
Age 65-74 years
(4, 2-6) n = 161Age 75-84 years
(5, 3-8) n = 116
Shiu et al.2 2006 Saskatchewan/Canada
N = 36,493 patients
Diabetes (15, 9-24) GPs (7, 4-13)
Jose et al.3 2015 Oman
N = 390 patients
General 56.9% of the participants visited the pharmacy at least 6 times a year No comparator
2008 Pharmacy Satisfaction Digest4 2008 United States
N = 34,454 patients
General 30 (mean) GPs, 2.9 (mean)
Unverified* Reports
Campbell5 1993 Unknown Unknown States that pharmacists see patients at least 5 times more than any other health professional
Kroon et al.6 1997 Unknown Diabetes States that people with diabetes see their pharmacist 7 times more than their family physician
Moose et al.7 2014 Unknown Unknown 35 (mean) GP, 4 (mean)

CVD, cardiovascular disease; GP, general practitioner; IQR, interquartile range.

*

No data or citation provided.